News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,853 Results
Type
Article (15977)
Company Profile (299)
Press Release (270571)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80580)
Career Advice (245)
Deals (13431)
Drug Delivery (41)
Drug Development (51409)
Employer Resources (34)
FDA (6053)
Job Trends (5313)
News (147016)
Policy (10341)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (981)
Accelerated approval (19)
Adcomms (14)
Allergies (82)
Alliances (21956)
ALS (125)
Alzheimer's disease (1044)
Antibody-drug conjugate (ADC) (243)
Approvals (6246)
Artificial intelligence (259)
Autoimmune disease (111)
Automation (9)
Bankruptcy (105)
Best Places to Work (4682)
BIOSECURE Act (8)
Biosimilars (106)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (351)
Cancer (3149)
Cardiovascular disease (244)
Career advice (218)
Career pathing (9)
CAR-T (219)
CDC (6)
Cell therapy (567)
Cervical cancer (14)
Clinical research (44309)
Collaboration (1155)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1121)
CRISPR (87)
C-suite (551)
Cystic fibrosis (114)
Data (4394)
Denatured (15)
Depression (94)
Diabetes (263)
Diagnostics (1422)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (51)
Drug shortages (4)
Duchenne muscular dystrophy (213)
Earnings (31954)
Editorial (26)
Employer branding (4)
Employer resources (32)
Events (52152)
Executive appointments (621)
FDA (7818)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (985)
Gene editing (183)
Generative AI (21)
Gene therapy (488)
GLP-1 (526)
Government (1198)
Grass and pollen (3)
Guidances (168)
Healthcare (6758)
HIV (28)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (194)
Immuno-oncology (39)
Indications (67)
Infectious disease (1227)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (23)
IPO (7384)
IRA (12)
Job creations (898)
Job search strategy (190)
JPM (44)
Kidney cancer (9)
Labor market (24)
Layoffs (251)
Leadership (9)
Legal (1475)
Liver cancer (42)
Longevity (11)
Lung cancer (422)
Lymphoma (249)
Machine learning (24)
Management (8)
Manufacturing (388)
MASH (130)
Medical device (2758)
Medtech (2767)
Mergers & acquisitions (6670)
Metabolic disorders (748)
Multiple sclerosis (111)
NASH (13)
Neurodegenerative disease (235)
Neuropsychiatric disorders (71)
Neuroscience (1978)
Neurotech (1)
NextGen: Class of 2026 (2095)
Non-profit (906)
Now hiring (30)
Obesity (341)
Opinion (132)
Ovarian cancer (131)
Pain (105)
Pancreatic cancer (162)
Parkinson's disease (233)
Partnered (13)
Patents (304)
Patient recruitment (329)
Peanut (43)
People (26796)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15550)
Phase 2 (20435)
Phase 3 (13179)
Pipeline (3268)
Policy (100)
Postmarket research (954)
Preclinical (6584)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (240)
Rare diseases (660)
Real estate (1472)
Recruiting (14)
Regulatory (10084)
Reports (20)
Research institute (1018)
Resumes & cover letters (33)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (124)
Series A (183)
Series B (135)
Service/supplier (1)
Sickle cell disease (82)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (17)
Startups (2013)
State (1)
Stomach cancer (5)
Supply chain (34)
Tariffs (23)
The Weekly (62)
Vaccines (344)
Venture capital (69)
Weight loss (189)
Women's health (25)
Worklife (3)
Date
Last 7 days (351)
Last 30 days (1165)
Last 365 days (17995)
2026 (1670)
2025 (18290)
2024 (20750)
2023 (22635)
2022 (27100)
2021 (28125)
2020 (23710)
2019 (16614)
2018 (12056)
2017 (14049)
2016 (12171)
2015 (14694)
2014 (10632)
2013 (7717)
2012 (7781)
2011 (7861)
2010 (7608)
Location
Africa (174)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18513)
Australia (3169)
California (7120)
Canada (1850)
China (782)
Colorado (247)
Connecticut (253)
Delaware (239)
Europe (40239)
Florida (913)
Georgia (214)
Hawaii (2)
Idaho (17)
Illinois (399)
India (35)
Indiana (175)
Iowa (8)
Japan (229)
Kansas (80)
Kentucky (10)
Louisiana (8)
Maine (11)
Maryland (742)
Massachusetts (5613)
Michigan (112)
Minnesota (248)
Mississippi (3)
Missouri (33)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1670)
New Mexico (13)
New York (1781)
North Carolina (828)
North Dakota (6)
Northern California (3495)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1279)
Puerto Rico (9)
Rhode Island (25)
South America (239)
South Carolina (9)
Southern California (2826)
Tennessee (42)
Texas (907)
United States (23520)
Utah (98)
Virginia (139)
Washington D.C. (37)
Washington State (595)
West Virginia (1)
Wisconsin (45)
286,853 Results for "switch therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy
January 27, 2026
·
9 min read
Press Releases
Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies
November 18, 2025
·
5 min read
Press Releases
Lilly’s orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial
December 18, 2025
·
24 min read
Manufacturing
FDA’s Manufacturing Designation Could Derisk Mid-Development Manufacturing Changes
The status could support staged transitions to new manufacturing processes, potentially mitigating some risks of high-stakes switches.
December 9, 2025
·
4 min read
·
Nick Paul Taylor
Biotech Bay
Switch Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Switch Therapeutics today announced that Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will present and host investor meetings at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 25, 2024
·
1 min read
Press Releases
Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions
October 6, 2025
·
5 min read
Obesity
Lilly’s Obesity Pill Maintains Weight Loss as Estimated Approval Timelines Inch Closer
Participants in a Phase III trial who switched to Eli Lilly’s orforglipron after 72 weeks of treatment with Wegovy or Zepbound largely maintained their weight loss for up to a year.
December 18, 2025
·
2 min read
·
Tristan Manalac
Biotech Bay
Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
Switch Therapeutics today announced that Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will participate in a virtual fireside chat at the Evercore ISI 2024 Emerging Biotech Conference on Thursday, February 29, 2024 at 1:05 p.m. ET (10:05 a.m. PT).
February 22, 2024
·
1 min read
Press Releases
New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies
September 24, 2025
·
15 min read
Press Releases
Molecular Switches Revolutionizing Drug Development & Therapeutic Precision
January 8, 2025
·
1 min read
1 of 28,686
Next
